CoreWeave (CRWV) is set to release its second-quarter 2025 earnings report after the market closes on Tuesday, Aug. 12. This report could prove to be a pivotal moment for the high-flying artificial intelligence (AI) infrastructure company as investors await key updates that may shape CRWV stock’s next move.
With CoreWeave riding the wave of surging demand for GPU cloud computing and recently landing major partnerships — including with OpenAI — anticipation is building for what the company has in store. Whether you’re already invested or watching from the sidelines, this upcoming event could provide fresh insights into CoreWeave’s growth trajectory and its role in the rapidly expanding AI ecosystem.
About CoreWeave Stock
CoreWeave is headquartered in Livingston, New Jersey, and specializes in providing GPU-optimized cloud infrastructure for AI workloads, serving major clients such as Microsoft (MSFT), OpenAI, Meta Platforms (META), and International Business Machines (IBM). After launching its initial public offering (IPO) on March 28, raising $1.5 billion, CoreWeave has surged to a market capitalization of around $54.7 billion.
Shares have seen a dramatic surge since the IPO at $40 per share, rallying to hit an all-time high of $187 on June 20. However, since mid-June, the stock has pulled back sharply, shedding around 39% from the high. CRWV stock is down 30% over the past month. That drop has been attributed to volatility concerns, cautious analyst downgrades, and a major proposed acquisition of Core Scientific (CORZ) that has spooked some investors. Despite the pullback, CoreWeave’s overall return since the IPO remains strong.
CRWV stock currently trades at 19.6 times forward sales, which is a premium compared to its peers.
CoreWeave’s Bottom Line Is In the Red
CoreWeave reported a mixed first-quarter performance, with results announced on May 14. The company generated $981.6 million in revenue, representing a staggering 420% year-over-year (YOY) surge and beating Wall Street estimates. On a non-GAAP basis, operating income rose sharply to $162.6 million, translating to a 17% margin, up from $25 million in the same quarter last year.
The company’s revenue backlog reached an impressive $25.9 billion, fueled by major contracts such as an $11.2 billion deal with OpenAI, offering strong revenue visibility ahead.
Despite the exceptional top-line growth, CoreWeave’s bottom line came under pressure. The company posted a net loss of $314.6 million, or $1.49 per share, significantly wider than the $129.2 million loss, or $0.62 per share, reported a year earlier. Adjusted net loss also expanded to $149.6 million from $23.6 million in the prior-year period.
CoreWeave Fans, Mark Your Calendars for Aug. 12
CoreWeave is gearing up for its Q2 earnings release, anticipating a robust quarter with revenue guidance set between $1.06 billion and $1.10 billion, reflecting continued strong growth from Q1. In parallel, its adjusted operating income guidance sits at $140 million to $170 million.
For the full year 2025, CoreWeave expects $4.9 billion to $5.1 billion in revenue, higher than its previous estimates. The firm intends to invest between $20 billion and $23 billion in total capital expenditures to support contracts and scale operations.
Its revenue target aligns closely with consensus analyst forecasts, which currently estimate Q2 revenue at around $1.08 billion. Additionally, loss per share is expected to come in at $0.49. Meanwhile, analysts anticipate loss per share to increase 100.2% to $2.14 in fiscal 2025, before improving by 74% to reach a loss of $0.56 in fiscal 2026.
What Do Analysts Expect for CoreWeave Stock?
Analyst sentiment on CoreWeave is decidedly mixed, with investors grappling to balance the company’s strong growth narrative against mounting execution and valuation concerns.
Mizuho downgraded the stock from “Outperform” to “Neutral,” citing volatility and risks around customer concentration, while still raising its price target from $70 to $150. Similarly, Stifel and Needham both moved to “Hold.” While Needham cited valuation concerns, Stifel mentioned the Core Scientific deal and “key near-term overhangs” as the reason for its downgrade, but also acknowledged the positive long-term benefits from the acquisition. Finally, Citizens JMP reaffirmed its “Market Perform” rating on CoreWeave, asserting that the stock’s current valuation already reflects most of its expected growth potential.
CoreWeave stock has a consensus “Hold" rating overall. Out of 20 analysts covering the tech stock, four recommend a “Strong Buy,” 15 stay cautious with a “Hold” rating, and one has a “Strong Sell” rating.
CRWV has surpassed its average analyst price target of $92.68, indicating its lofty valuation. Nevertheless, the Street-high target price of $185 suggests 78% potential upside from here.
